Holen Sie sich die Stockscreener-App
262.21
0.90%
2.33
Handel nachbörslich:
262.21
Schlusskurs vom Vortag:
$259.88
Offen:
$260.23
24-Stunden-Volumen:
1.08M
Relative Volume:
0.85
Marktkapitalisierung:
$43.16B
Einnahmen:
$16.63B
Nettoeinkommen (Verlust:
$1.39B
KGV:
32.50
EPS:
8.0674
Netto-Cashflow:
$2.12B
1W Leistung:
-1.46%
1M Leistung:
+0.17%
6M Leistung:
+56.69%
1J Leistung:
+32.32%
1-Tages-Spanne:
$257.30
$263.82
1-Wochen-Bereich:
$252.56
$274.27
52-Wochen-Spanne:
$154.50
$277.40
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
262.21 | 43.16B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
662.24 | 244.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.20 | 155.50B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
397.77 | 57.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
171.33 | 48.30B | 7.23B | 1.41B | 1.09B | 4.979 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-30 | Fortgesetzt | UBS | Buy |
| 2026-06-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2026-03-09 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-03-06 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2026-03-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-03 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-09 | Hochstufung | Jefferies | Hold → Buy |
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-13 | Eingeleitet | BTIG Research | Buy |
| 2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-03-17 | Eingeleitet | Truist | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Hochstufung | CFRA | Sell → Hold |
| 2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
| 2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-09 | Eingeleitet | UBS | Buy |
| 2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
| 2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Bestätigt | Stifel | Buy |
| 2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
| 2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock - Zacks Investment Research
Leerink Partners Adjusts IQVIA Holdings Price Target to $310 From $280 - www.marketscreener.com
Across 50 trials, 85% of IQVIA's predictions were on target or close. - Stock Titan
Mizuho Adjusts Price Target on IQVIA Holdings to $300 From $275 - marketscreener.com
IQVIA Holdings Inc. R (QTS.HM) Q2 FY2026 earnings call transcript - Yahoo Finance
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Evercore ISI Adjusts Price Target on IQVIA Holdings to $290 From $275, Maintains Outperform Rating - marketscreener.com
Is the Market Repricing Iqvia Holdings (NYSE:IQV) Too Quickly? - Kalkine Media
IQVIA (NYSE:IQV) Bets on AI to Power Clinical Research - Kalkine Media
RBC raises target for IQVIA Holdings stock from USD 247 to USD 319 - AD HOC NEWS
A Look at IQVIA Holdings Inc (IQV) After 3.0% Gain -- GF Value $249.70 vs Price $266.09 - GuruFocus
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA Holdings Inc. (IQV) stock price, news, quote and historyYahoo Finance - Yahoo Finance Singapore
Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity - Zacks Investment Research
Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity - TradingView
Judge 'Flummoxed' By Forum Claim In IQVIA's Poaching Suit - Law360
A Look at IQVIA Holdings Inc (IQV) After 3.0% Decline -- GF Value $249.48 vs Price $260.72 - GuruFocus
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - marketwatch.com
IQVIA Holdings Inc. (IQV) Options Chain - Yahoo! Finance Canada
IQVIA Holdings, Inc. (IQV) Stock Forecasts - Yahoo! Finance Canada
IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026 - Business Wire
IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026 - FinancialContent
RBC Raises Price Target on IQVIA Holdings to $319 From $247, Keeps Outperform Rating - Yahoo Finance
IQVIA Holdings (NYSE:IQV) Stock Forecast & Analyst Predictions - Simply Wall Street
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors - marketwatch.com
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions - GlobeNewswire Inc.
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - marketwatch.com
Europe Clinical Data Analytics Market Outlook 2026-2033 | AI, Cloud Deployment and Data-Driven Healthcare Adoption Accelerate Across the Region - GlobeNewswire Inc.
IQVIA Holdings stock reports 8.7 percent revenue growth - AD HOC NEWS
IQVIA Holdings stock heads into the open after a 0.8 percent gain - AD HOC NEWS
IQVIA Holdings (IQV) Completes $2 Billion Senior Notes Offering to Refinance Debt - GuruFocus
Form 8K IQVIA Holdings Inc For: 23 September By Investing.com - Investing.com UK
IQVIA Raises $2.0 Billion in 6.375% Senior Notes Due 2034 to Refinance Debt - TradingView
IQVIA (NYSE:IQV) Nears Breakout With 10/10 Technical Strength and 9/10 Setup - ChartMill
iqvia holdings inc. Earnings dates - RTTNews
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - Fortune
IQVIA Holdings stock heads into the open after a 1.12 percent drop - AD HOC NEWS
IQVIA Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring Growth Potential With A 4.33% Upside - DirectorsTalk Interviews
Rare Disease Contract Research Organization (CRO) Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook - GlobeNewswire Inc.
IQVIA Holdings (IQV) Prices $2b Notes, Does The Stock Look Fairly Valued? - Yahoo Finance
IQVIA (IQV) Stock Could Be Undervalued After Its 42% Run - Yahoo Finance
Iqvia Holdings Stock Price Forecast. Should You Buy IQV? - StockInvest.us
IQVIA Holdings Inc (IQV): GF Score of 92 Signals Strong Outperfo - GuruFocus
IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know - TradingView
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
A Strong Rebound Case of IQVIA Holdings (IQV) - Yahoo Finance
IQVIA Holdings stock gains support as $2 billion notes offering underpins balance sheet - ad-hoc-news.de
IQVIA Holdings Announces $2 Billion Senior Notes Offering - The Globe and Mail
IQVIA Holdings Announces $2 Billion Senior Notes Offering - The Globe and Mail
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iqvia Holdings Inc-Aktie (IQV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| JAMES G BERKSHIRE | Officer |
Sep 02 '26 |
Proposed Sale |
261.32 |
2,668 |
697,215 |
0 |
| Berkshire James G. | See Remarks |
Sep 02 '26 |
Sale |
261.33 |
2,668 |
697,228 |
10,890 |
| WALTER STAUB | Officer |
Aug 03 '26 |
Proposed Sale |
232.68 |
5,500 |
1,279,740 |
0 |
| STAUB W RICHARD | See Remarks |
Aug 03 '26 |
Sale |
232.68 |
5,500 |
1,279,740 |
13,312 |
| Patel Bhavik | See Remarks |
Jul 31 '26 |
Sale |
235.27 |
1,855 |
436,426 |
1,348 |
| BHAVIK PATEL | Officer |
Jul 31 '26 |
Proposed Sale |
235.27 |
1,855 |
436,426 |
0 |
| ARI BOUSBIB | Officer |
Jul 29 '26 |
Proposed Sale |
245.50 |
106,279 |
26,091,897 |
0 |
| ERIC SHERBET | Officer |
Jul 29 '26 |
Proposed Sale |
249.16 |
5,000 |
1,245,775 |
0 |
| Sherbet Eric | See Remarks |
Jul 29 '26 |
Sale |
249.16 |
5,000 |
1,245,800 |
20,999 |
| Cherofsky Keriann | See Remarks |
Jul 29 '26 |
Sale |
245.21 |
558 |
136,827 |
2,989 |
0.38%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):